Top compounds associated with response to IPO4


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan gCSI pan-cancer AAC 0.087 0.1
mRNA BRD8899 CTRPv2 pan-cancer AAC -0.06 0.1
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.055 0.1
mRNA Doxorubicin gCSI pan-cancer AAC 0.084 0.1
mRNA IU1 CTRPv2 pan-cancer AAC 0.061 0.1
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.045 0.1
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.07 0.1
mRNA AZD-7545 CTRPv2 pan-cancer AAC 0.057 0.1
mRNA cyanoquinoline 11 CTRPv2 pan-cancer AAC 0.082 0.1
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.052 0.1
Download CSV